DOCSLIB.ORG

March 2017 Newsletter

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
March 2017 Newsletter NEWSLETTER March 2017 to advance education and research in the science of www.bap.org.uk psychopharmacology for the public benefit INSIDE 1–2 Jeff Nye Obituary 3–4 2017 BAP Elections 5 Prof David Nutt Receives Honorary Doctorate from the University of Bath; Prof Trevor Robbins to Recieve SOBP’s 2017 Gold Medal Award; In Vivo Awards 6–7 Summer Meeting 2017 8 Launch of BAP Early Career Membership; Launch of the anti-dementia Guidelines; BAP Consensus Guideline Statements; Buddy Scheme at the 2017 Summer Meeting 9 BAP Session at the BNA Meeting; Summer Meeting Archive; Brain imaging study of cannabis dependence; BAP at the 2017 Cheltenham Science Festival 10–11 BOOK REVIEW: My Brain is Out of Control 12 Media Activities 13–14 Education Events Jeff Nye Obituary With deepest sorrow, we mourn the untimely passing of our friend and esteemed colleague, British Association for Jeffrey S. Nye, MD, Psychopharmacology PhD, Vice President, 36 Cambridge Place Neuroscience Innovation Hills Road and Scientific Partnership Cambridge Strategy, Johnson & CB2 1NS Johnson Innovation. He 01223 358 395 was 57 years old. Jeff was a brilliant neurologist Executive Officer Susan Chandler • [email protected] and neuroscientist and a highly respected academic. It is hard to fathom the Assistant to the Executive Officer Lynne Harmer • [email protected] magnitude of this loss to our community. All of us who were lucky enough to have worked with Jeff know Online Resources and Communications Developer he represented the finest ideals in science. He was Sarah Channing-Wright • [email protected] extraordinarily dedicated, passionate about his work, intelligent, and curious. Jeff always pushed forward For m @BAPsych in the quest to learn more and to share all that was discovered. He led the formation of many productive BritishAssociationforPsychopharmacology continued on page 2 /company/britishassociationforpsychopharmacology The British Association for Psychopharmacology is registered in England +BapOrgUk as a Private Company No 5866899. Registered Charity No 277825. continued from page 1 scientific collaborations with universities and We were very lucky to have Jeff serve as a Co-opted research consortia, and advocated for advancement Member of the BAP Council from 2012–2015. In of science in academia through many sponsorships addition to enjoying his dry wit and humour, Jeff’s and philanthropy. Jeff previously held several roles at industry perspective proved valuable when planning the Janssen Pharmaceutical Companies of Johnson BAP events. He took part in a number of BAP & Johnson, including Chief Medical Officer of the symposia over the years and was also a member of East Coast Research and Early Development unit, the panel of the inaugural BAP Plenary Mental Health Vice President of Experimental Medicine, and Vice Session in 2011 “Mental health, neuroscience and the President of CNS Development. His professional life wellbeing of society”. was marked by tireless service to the larger scientific –– Susan Chandler, BAP Office community, by a desire to ask and answer important scientific questions and, above all, to make a real I knew Jeff through his many impressive difference with his research. He was honored with contributions to science and to scientific societies, numerous awards recognizing his scientific acumen including the BAP. He was always enthusiastic about and his dedication to improving the health of people research and keen to discuss new findings. I had worldwide. Jeff will be missed most acutely by his the pleasure of working with Jeff on several projects loving family but also by his many admiring colleagues, and we also co-authored articles together. During both here at Janssen and at Johnson & Johnson and in this time, I had the opportunity to find out what a the larger neuroscience community. We have lost an thoughtful, warm, friendly and kind person he was. important and beloved family member. We express He was also a devoted family man. I will greatly miss our deep sympathy to his beloved wife, Miriam our wonderful discussion on a wide range of topics, Chaloff, his sons, Maxwell and Leo Nye, his extended including neuroethics. One of my favourite memories family, and all of his friends and loved ones. We will is the day that he, Alan Frazer and I went sightseeing miss Jeff very much. around Tokyo after a CINP Meeting in 2015. We had a fabulous afternoon with lots of laughs! In my –– William N. Hait, Global Head, Janssen Research & lounge at home is the photo of the three of us at the Development top of Tokyo Tower, with an amazing view of the City Husseini K. Manji, Global Head, Neuroscience Therapeutic behind us – It always makes me smile. Area, Janssen Research & Development –– Barbara Sahakian, BAP President 2012-2014 Robert Urban, Head, Johnson & Johnson Innovation, Boston Published in The New York Times on Mar. 8, 2017 For those who may wish to make a donation to Johns Hopkins in honor of Jeff Nye, please use the following link and instructions to donate electronically: https://secure.jhu.edu/form/somt Once you are in the form, Step 2 offers a drop down box with various funds; The Solomon H. Snyder Fund for MD-PhD Education and Research Training is listed. 2 March 2017 2017 Election for BAP Officers The following vacancies will arise on BAP Council in July: and Council Members Honorary General Secretary The main role of Council members is to represent Dr Maxine Patel ends her 3-year term the views of the membership and use their expertise to help shape BAP policies and activities. There are three Council meetings each year, two in London Secretary for Non-Clinical External Affairs and a third meeting held on the first day of the Dr Paula Moran ends her 3-year term Summer Meeting. These meetings are extremely important to the running of BAP. Over the course Two Elected Council Member posts of the year set agenda items include the planning the summer meeting, reviewing the Association’s (Post 1) Dr Sarah Bailey will retire finances and membership, liaison with outside (Post 2) Dr James Stone will retire bodies and public engagement, updating the BAP’s preclinical and clinical teaching programmes and Nominations are invited from Full, Early Career, assessing the progress of the two BAP journals, Honorary or Retired Full Members for the above Journal of Psychopharmacology and Therapeutic posts and should be supported by two Full, Early Advances in Psychopharmacology. The lead in many Career, Honorary or Retired Full Members. Separate of these areas is taken by the BAP’s Elected Officers emails should be sent to Susan Chandler from the supported by the BAP’s administrative office. Proposer, Seconder and Nominee, to arrive no later However the Officers very much rely on the Council than MONDAY 8 MAY. members to assist and guide them. There is much Voting will be online via the website only from scope for Council members to take on additional Monday 15 May and will close on MONDAY 3 JULY. responsibility for certain areas of work and join sub- The results will be announced at the Annual General committees. The work of a Council member involves Meeting on Monday 24 July in Harrogate. a lot of work but is also very rewarding and a lot of The BAP aims to represent the interests of all fun. You have the opportunity to influence the work psychopharmacologists. Council asks Members to bear this of BAP, represent your colleagues and meet a lot of in mind when making nominations for the election, to ensure great people. Being a Council member is not a pre- a balance of expertise. Please refer to the BAP Equality and requisite to stand for election to an Officer position Diversity Statement www.bap.org.uk/equality.php but in reality the responsibility and experience needed to fulfil an Officer post means that most of those who have been elected to Officer positions have Nominees had experience of serving on Council. If anyone is All nominees must provide a mini-biography, head- interested in standing as a Council Member and and-shoulders photograph and statement of intent would like more information I would encourage by THURSDAY 11 MAY. them to contact either myself or Susan Chandler for an informal discussion. Secretaries serve a 4-year term Maxine Patel, General Secretary Council Members serve a 4-year term. Council Meetings Three each year: March (London, full day), July (Sunday morning in association with the Summer Meeting), October/November (London, full afternoon). March 2017 3 Expenses b) Council members will be informed if no nominations have been received by the deadline Council Members do not receive payment for and, if they wish, give names of people whom anything they do for the BAP. BAP will reimburse they consider suitable for the Nominations Sub- standard travel expenses and hotel accommodation Committee to consider if Council members are unable to cover these from an alternative source. c) The Nominations Sub-Committee will comprise the current Past-President, President, President- The following procedure will be implemented elect and one of the Secretaries if necessary: a) In the event of no nomination/s being received by the closing date, the Nominations Sub- Committee should find at least one person to be asked to put their name forward for election Current Officers and Council See website for biographies www.bap.org.uk/council ELECTED OFFICERS ELECTED COUNCIL MEMBERS Professor Jo Neill Dr Sarah Bailey (Post 1) President Professor Allan Young Dr James Stone (Post 2) President-Elect Dr Carmine Pariante (Post 3) Professor Paul Harrison Past-President Dr Rachel Upthegrove (Post 4) (filling a casual vacancy until July 2018) Dr Elizabeth Tunbridge Honorary Treasurer Professor Ciara McCabe (Post 5) Dr Mitul Mehta Dr Peter Talbot (Post 6) Meetings Secretary Dr Maxine Patel Dr Paul Stokes (Post 7) Honorary General Secretary Dr Angela Roberts (Post 8) Professor Jeremy Hall Secretary for Clinical External Affairs OTHER VOTING MEMBERS OF COUNCIL Dr Paula Moran Secretary for Non-Clinical External Affairs Jonas Eberhard 4 March 2017 Professor David Nutt Receives Honorary Doctorate from the University of Bath Sarah Bailey Prof David Nutt, BAP’s lifetime achievement winner 2016, was recently awarded his first ever honorary doctorate.
Load more

Recommended publications
  • The Use of Non-Human Primates in Research in Primates Non-Human of Use The
    The use of non-human primates in research The use of non-human primates in research A working group report chaired by Sir David Weatherall FRS FMedSci Report sponsored by: Academy of Medical Sciences Medical Research Council The Royal Society Wellcome Trust 10 Carlton House Terrace 20 Park Crescent 6-9 Carlton House Terrace 215 Euston Road London, SW1Y 5AH London, W1B 1AL London, SW1Y 5AG London, NW1 2BE December 2006 December Tel: +44(0)20 7969 5288 Tel: +44(0)20 7636 5422 Tel: +44(0)20 7451 2590 Tel: +44(0)20 7611 8888 Fax: +44(0)20 7969 5298 Fax: +44(0)20 7436 6179 Fax: +44(0)20 7451 2692 Fax: +44(0)20 7611 8545 Email: E-mail: E-mail: E-mail: [email protected] [email protected] [email protected] [email protected] Web: www.acmedsci.ac.uk Web: www.mrc.ac.uk Web: www.royalsoc.ac.uk Web: www.wellcome.ac.uk December 2006 The use of non-human primates in research A working group report chaired by Sir David Weatheall FRS FMedSci December 2006 Sponsors’ statement The use of non-human primates continues to be one the most contentious areas of biological and medical research. The publication of this independent report into the scientific basis for the past, current and future role of non-human primates in research is both a necessary and timely contribution to the debate. We emphasise that members of the working group have worked independently of the four sponsoring organisations. Our organisations did not provide input into the report’s content, conclusions or recommendations.
    [Show full text]
  • Cognitive Enhancement and the Emergence of Personhood
    http://dx.doi.org/10.5007/1677-2954.2021.e80030 FROM THE NECESSITY OF BEING HUMAN TO THE POSSIBILITY OF PURSUING A GOOD LIFE: COGNITIVE ENHANCEMENT AND THE EMERGENCE OF PERSONHOOD GIOVANA LOPES1 (UNIVERSITÀ DI BOLOGNA/Italia) BRUNELLO STANCIOLI2 (UFMG/Brasil) ABSTRACT Throughout human history, cognition enhancement has not only been a constant, but also imperative for our species evolution and well-being. However, philosophical assumptions that enhancing cognition by biomedical means goes against some immutable human nature, combined with the lack of conclusive data about its use on healthy individuals and long-term effects, can sometimes result in prohibitive approaches. In this context, the authors seek to demonstrate that cognition enhancement, whether by “natural” or biotechnological means, is essential to the emergence of personhood, and to existence of an autonomous life that is guided by a person’s own conception of the good. In order to do so, the main possibilities of enhancing cognition through biotechnologies, along with its benefits and potentialities, as well as its risks and limitations, will be presented. Following Savulescu and Sandberg’s account on cognitive enhancement, it will be argued that it constitutes both a consumption good, being desirable and happiness-promoting to have well-functioning cognition, and a capital good that reduces risks, increases earning capacity, and forms a key part of human capital. Finally, having in mind that progress in the field of biotechnology aimed at cognition enhancement may improve a person’s (and society’s) well-being, the authors will argue that further research in the field is necessary, especially studies that takes into consideration dimensions such as dose, individual characteristics and task characteristics.
    [Show full text]
  • TREVOR W. ROBBINS, CBE FRS Fmedsci Fbpss
    TREVOR W. ROBBINS, CBE FRS FMedSci FBPsS Professor of Cognitive Neuroscience and Experimental Psychology Trevor Robbins is accepting applications for PhD students. Email: [email protected] Office Phone: +44 (0)1223 (3)33551 Websites: • http://www.neuroscience.cam.ac.uk/directory/profile.php?Trevor Download as vCard Biography: Trevor Robbins was appointed in 1997 as the Professor of Cognitive Neuroscience at the University of Cambridge. He was elected to the Chair of Experimental Psychology (and Head of Department) at Cambridge from October 2002. He is also Director of the Behavioural and Clinical Neuroscience Institute (BCNI), jointly funded by the Medical Research Council and the Wellcome Trust. The mission of the BCNI is to inter-relate basic and clinical research in psychiatry and neurology for such conditions as Parkinson's, Huntington's, and Alzheimer's diseases, frontal lobe injury, schizophrenia, depression, drug addiction and developmental syndromes such as attention deficit/hyperactivity disorder. Trevor is a Fellow of the British Psychological Society (1990), the Academy of Medical Sciences (2000) and the Royal Society (2005). He has been President of the European Behavioural Pharmacology Society (1992-1994) and he won that Society's inaugural Distinguished Scientist Award in 2001. He was also President of the British Association of Psychopharmacology from 1996 to 1997. He has edited the journal Psychopharmacology since 1980 and joined the editorial board of Science in January 2003. He has been a member of the Medical Research Council (UK) and chaired the Neuroscience and Mental Health Board from 1995 until 1999. He has been included on a list of the 100 most cited neuroscientists by ISI, has published over 600 full papers in scientific journals and has co-edited seven books (Psychology for Medicine: The Prefrontal Cortex; Executive and Cognitive Function: Disorders of Brain and Mind 2:Drugs and the Future: The Neurobiology of Addiction; New Vistas.
    [Show full text]
  • College Annual Report and Accounts 2013-2014
    DOWNING COLLEGE CAMBRIDGE ANNUAL REPORT AND ACCOUNTS for the financial year ending 30 June 2014 The West Range ©Tim Rawle www.dow.cam.ac.uk 2 Contents 5. Financial Highlights 6. Members of the Governing Body 9. Officers and Principal Professional Advisors 11. Report of the Governing Body 67. Financial Statements 77. Principal Accounting Statements 78. Consolidated Income & Expenditure Account 79. Consolidated Statement of Total Recognised Gains and Losses 80. Consolidated Balance Sheet 82. Consolidated Cashflow Statement 85. Notes to the Accounts 3 4 Financial HIGHlIGHtS 2014 2013 2012 £ £ £ Highlights Income Income 10,155,889 9,663,733 9,239,544 Donations and Benefactions Received 5,292,916 3,124,484 2,304,365 Financial | Conference Services Income 2,042,832 2,130,085 1,875,620 Operating Surplus/(Deficit) 320,009 336,783 306,969 2014 Cost of Space (£ per m2) £150.87 £150.20 £156.65 College Fees: June Publicly Funded Undergraduates £4,068/£4,500 £3,951/£4,500 £3,951 30 Privately Funded Undergraduates £7,350 £6,999 £6,000 Graduates £2,424 £2,349 £2,289 Ended loss on College Fee per Student £2,436 £2,630 £1,995 Year Capital Expenditure Investment in Historical Buildings 1,751,811 573,388 446,851 Investment in Student Accommodation 1,499,507 740,562 2,784,000 Assets Free Reserves 8,349,966 13,372,300 11,499,498 Investment Portfolio 35,775,344 34,917,793 31,785,279 Spending Rule Amount 1,617,819 1,543,197 1,505,631 total Return 7.6% 9.2% 6.2% total Return: 3 year average 7.7% 10.3% 10.6% Return on Property 5.8% 7.6% 11.4% Return on Property:
    [Show full text]
  • Human Functional Brain Imaging 1990–2009
    Portfolio Review Human Functional Brain Imaging 1990–2009 September 2011 Acknowledgements The Wellcome Trust would like to thank the many people who generously gave up their time to participate in this review. The project was led by Claire Vaughan and Liz Allen. Key input and support was provided by Lynsey Bilsland, Richard Morris, John Williams, Shewly Choudhury, Kathryn Adcock, David Lynn, Kevin Dolby, Beth Thompson, Anna Wade, Suzi Morris, Annie Sanderson, and Jo Scott; and Lois Reynolds and Tilli Tansey (Wellcome Trust Expert Group). The views expressed in this report are those of the Wellcome Trust project team, drawing on the evidence compiled during the review. We are indebted to the independent Expert Group and our industry experts, who were pivotal in providing the assessments of the Trust’s role in supporting human functional brain imaging and have informed ‘our’ speculations for the future. Finally, we would like to thank Professor Randy Buckner, Professor Ray Dolan and Dr Anne-Marie Engel, who provided valuable input to the development of the timelines and report. The2 | Portfolio Wellcome Review: Trust Human is a Functional charity registeredBrain Imaging in England and Wales, no. 210183. Contents Acknowledgements 2 Key abbreviations used in the report 4 Overview and key findings 4 Landmarks in human functional brain imaging 10 1. Introduction and background 12 2 Human functional brain imaging today: the global research landscape 14 2.1 The global scene 14 2.2 The UK 15 2.3 Europe 17 2.4 Industry 17 2.5 Human brain imaging
    [Show full text]
  • 2017 Annual Report
    RESEARCH FOR RECOVERY ACCELERATING PATHWAYS TO MENTAL HEALTH BRAIN & BEHAVIOR RESEARCH FOUNDATION 2017 ANNUAL REPORT Awarding research grants to develop improved treatments, cures, and methods of prevention for mental illness. www.bbrfoundation.org 1 FROM DISCOVERY TO RECOVERY Mission The Brain & Behavior Research Foundation (BBRF) is committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research. Vision To dramatically improve the lives of those living with mental illness and ultimately enable them to live full, happy, and productive lives. 100% of all donor contributions for research are invested in grants that lead to discoveries in understanding the causes and improving treatments for brain and behavior disorders in children and adults including addiction, ADHD, anxiety, autism, bipolar disorder, borderline personality disorder, depression, eating disorders, OCD, PTSD, schizophrenia, and suicide prevention. For 30 years we have awarded more than $380 million, to more than 4,500 scientists carefully selected by our prestigious Scientific Council. 2 ANNUAL REPORT 2017 BBRF GRANTS SUPPORT THE MOST PROMISING IDEAS IN BRAIN RESEARCH. We invest in: Basic Research to understand what happens in the brain to cause mental illness New Technologies to advance or create new ways of studying and understanding the brain Diagnostic Tools And Early Intervention to recognize early signs of mental illness and begin treatment as early as possible Next-Generation Therapies
    [Show full text]
  • Trustees' Report and Financial Statements
    The Royal Society Trustees’ report and financial statements for the year ended 31 March 2013 Trustees’ report and financial statements For the year ended 31 March 2013 Trustees Statutory Auditor The Trustees of the Society are the BDO LLP members of its Council, who are elected 55 Baker Street by the Fellowship. Council is chaired by the London President of the Society. During 2012/13, W1U 7EU the members of Council were as follows: Bankers President The Royal Bank of Scotland Sir Paul Nurse 1 Princess Street London Foreign Secretary EC2R 8BP Professor Martyn Poliakoff CBE Investment Managers Physical Secretary Rathbone Brothers PLC Professor John Pethica 1 Curzon Street London Biological Secretary W1J 5FB Dame Jean Thomas DBE Internal Auditors Treasurer PricewaterhouseCoopers LLP Sir Peter Williams * Cornwall Court Professor Anthony Cheetham ** 19 Cornwall Street Members of Council Birmingham Professor Gillian Bates B3 2DT Professor Andrew Blake * Professor Geoffrey Boulton OBE ** Sir John Beddington CMG ** Registered charity No 207043 Dr Simon Campbell CBE Professor John Collinge CBE Registered Address Professor Athene Donald DBE ** 6 – 9 Carlton House Terrace Professor Peter Donnelly * London SW1Y 5AG Professor Carlos Frenk ** Professor Alexander Halliday royalsociety.org Professor Judith Howard CBE Professor Frances Kirwan ** Professor Ottoline Leyser CBE ** Dr Robin Lovell-Badge Professor John McWhirter * Professor Kim Nasmyth * Professor Roger Owen ** Dame Linda Partridge * Professor Timothy Pedley ** Professor Trevor Robbins * Professor Wilson Sibbett * Sir Christopher Snowden * Professor Nicholas Tonks Professor John Wood ** * up to 30 November 2012 ** since 1 December 2012 Executive Director Dr Julie Maxton Cover: Bicontinuous, interfacially jammed emulsion gel capsule. Courtesy of Dr Paul Clegg, Industry Fellow.
    [Show full text]
  • Treating Addiction in the Clinic, Not the Courtroom: Using Neuroscience and Genetics to Abandon the Failed War on Drugs
    TREATING ADDICTION IN THE CLINIC, NOT THE COURTROOM: USING NEUROSCIENCE AND GENETICS TO ABANDON THE FAILED WAR ON DRUGS TENEILLE R. BROWN* ABSTRACT The opioid addiction epidemic has been one of the most overwhelming public health crises our country has faced. It has also created a legal crisis, as its aftermath spills over into the criminal, civil, and family courts. One estimate puts its cost to the U.S. economy at over $500 billion in 2015.1 More than a hundred people die every day from an opioid overdose,2 with that number likely increasing during the COVID-19 pandemic. The pressure on law enforcement, emergency responders, behavioral health services, and jails is crippling our cities and counties. This Article is an attempt to relieve some of that pressure by doing something we should have done a long time ago: change the way we think about and treat addiction. At least 2.3 million people in the United States have opioid use disorder (OUD), yet over 60% do not have access to evidence-based treatment.3 Of the over 14,000 drug treatment programs in the country, most are not staffed with a single licensed medical practitioner.4 Close your eyes and try to imagine 60% of people with lung cancer not having access to chemotherapy or radiation, or sending your mother to a cancer clinic that was not staffed with * Teneille R. Brown, J.D., is a Professor of Law at the University of Utah, S.J. Quinney College of Law, and an adjunct Professor in the Department of General Internal Medicine.
    [Show full text]
  • BNA2015-Abstract-Book.Pdf
    BNA2015: Festival of Neuroscience Poster Abstracts 12‐14 April 2015 EICC, Edinburgh, UK Citations The recommended citation for an abstract in this volume is as follows: British Neurosci. Assoc. Abstr., Vol. 23: Pxx, 2015 ISSN 1345‐8301 2015 Contents Sunday 12 April 2015 - Poster Session 1 Page Floor plan 4 Theme A: Development 5 B: Molecular, Cellular and Synaptic Mechanisms 24 C: Sensory and Motor Systems 68 D: Learning, Memory and Cognition 104 F: Nervous System Disorders 173 G: Methods and Techniques 234 H: Autonomic Nervous System 251 Monday 13 April – Poster Session 2 Page Floor plan 261 Theme A: Development 262 B: Molecular, Cellular and Synaptic Mechanisms 286 C: Sensory and Motor Systems 332 D: Learning, Memory and Cognition 368 E: Sleep, Circadian and Neuroendocrine Mechanisms 434 F: Nervous System Disorders 453 G: Methods and Techniques 518 Tuesday 14 April – Poster Session 3 Page Floor plan 537 Theme A: Development 538 B: Molecular, Cellular and Synaptic Mechanisms 560 C: Sensory and Motor Systems 605 D: Learning, Memory and Cognition 637 E: Sleep, Circadian and Neuroendocrine Mechanisms 704 F: Nervous System Disorders 723 G: Methods and Techniques 782 Conflict of interest declarations 798 Poster Reference Explanation P2-F-012 Poster board number Day Theme 1=Sunday A: Development 2=Monday B: Molecular, Cellular and Synaptic Mechanisms 3=Tuesday C: Sensory and Motor Systems D: Learning, Memory and Cognition E: Sleep, Circadian and Neuroendocrine Mechanisms F: Nervous System Disorders G: Methods and Techniques H: Autonomic Nervous
    [Show full text]
  • Acknowledgment of Reviewers, 2009
    Proceedings of the National Academy ofPNAS Sciences of the United States of America www.pnas.org Acknowledgment of Reviewers, 2009 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2009. Their generous contribution is deeply appreciated. A R. Alison Adcock Schahram Akbarian Paul Allen Lauren Ancel Meyers Duur Aanen Lia Addadi Brian Akerley Phillip Allen Robin Anders Lucien Aarden John Adelman Joshua Akey Fred Allendorf Jens Andersen Ruben Abagayan Zach Adelman Anna Akhmanova Robert Aller Olaf Andersen Alejandro Aballay Sarah Ades Eduard Akhunov Thorsten Allers Richard Andersen Cory Abate-Shen Stuart B. Adler Huda Akil Stefano Allesina Robert Andersen Abul Abbas Ralph Adolphs Shizuo Akira Richard Alley Adam Anderson Jonathan Abbatt Markus Aebi Gustav Akk Mark Alliegro Daniel Anderson Patrick Abbot Ueli Aebi Mikael Akke David Allison David Anderson Geoffrey Abbott Peter Aerts Armen Akopian Jeremy Allison Deborah Anderson L. Abbott Markus Affolter David Alais John Allman Gary Anderson Larry Abbott Pavel Afonine Eric Alani Laura Almasy James Anderson Akio Abe Jeffrey Agar Balbino Alarcon Osborne Almeida John Anderson Stephen Abedon Bharat Aggarwal McEwan Alastair Grac¸a Almeida-Porada Kathryn Anderson Steffen Abel John Aggleton Mikko Alava Genevieve Almouzni Mark Anderson Eugene Agichtein Christopher Albanese Emad Alnemri Richard Anderson Ted Abel Xabier Agirrezabala Birgit Alber Costica Aloman Robert P. Anderson Asa Abeliovich Ariel Agmon Tom Alber Jose´ Alonso Timothy Anderson Birgit Abler Noe¨l Agne`s Mark Albers Carlos Alonso-Alvarez Inger Andersson Robert Abraham Vladimir Agranovich Matthew Albert Suzanne Alonzo Tommy Andersson Wickliffe Abraham Anurag Agrawal Kurt Albertine Carlos Alos-Ferrer Masami Ando Charles Abrams Arun Agrawal Susan Alberts Seth Alper Tadashi Andoh Peter Abrams Rajendra Agrawal Adriana Albini Margaret Altemus Jose Andrade, Jr.
    [Show full text]
  • Trevor W Robbins CBE FRS Fmedsci Phd Trevor Has Been Professor Of
    Trevor W Robbins CBE FRS FMedSci PhD Trevor has been Professor of Cognitive Neuroscience at the University of Cambridge from 1997. He was also Professor of Expt. Psychology and Head of the Dept. of Psychology from 2002-2017. He has been based in Cambridge for most of his scientific career, receiving his PhD there in 1975. He is a Fellow of the British Psychological Society (1990), the British Pharmacological Society (2017), the Academy of Medical Sciences (2000), and the Royal Society (2005), the most prestigious science society in the U.K. He has published over 800 full papers, with an H index of about 196. He has co-edited eight books, most recently Translational Neuropsychopharmacology (Springer, 2016)). He edits Psychopharmacology (since 1980) and Current Opinion in the Behavioral Sciences and is an editorial advisor for Science. Trevor directs the ‘Behavioural and Clinical Neuroscience Institute’ (BCNI) (funded by the MRC and Wellcome Trust) the mission of which is to enhance translation from basic to clinical neuroscience with particular reference to impulsive-compulsive disorders, including drug addiction. His interest in translation began with his co-invention in 1987 of the CANTAB computerized neuropsychological battery, which is currently used in over 700 institutes and clinical centres world-wide. Among several prizes, he received the Distinguished Scientific Contribution Award for 2011 from the American Psychological Association. He was made a CBE in the U.K. New Year’s Honours list. in 2012 "for services to medical research". In 2014 he shared the ‘Brain Prize’ of the Grete Lundbeck European Brain Research Foundation, the most valuable in neuroscience, for his work on human mental disorders.
    [Show full text]
  • The Relative Contribution of Goal-Directed and Habit Systems To
    Psychiatria Danubina, 2017; Vol. 29, Suppl. 3, pp 203-213 Conference paper © Medicinska naklada - Zagreb, Croatia THE RELATIVE CONTRIBUTION OF GOAL-DIRECTED AND HABIT SYSTEMS TO PSYCHIATRIC DISORDERS Sophie Woodhead1,2 & Trevor Robbins3 1Clare College, Cambridge, UK 2Imperial College Medical School, London, UK 3Department of Experimental Psychology University of Cambridge, Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK SUMMARY Psychiatric disorders may be caused by underlying imbalances between goal-directed and habit systems in the brain. Numerous studies have aimed to establish whether this is because of a goal-directed system deficit, enhanced habit system, or both. This transdiagnostic approach to studying psychiatric disorders is increasingly popular. Maladaptive habitual behaviour is present in many disorders. It is the principal observation in disorders of compulsivity and is also present in other psychiatric disorders that are not primarily characterised by compulsive behaviour. The psychopathology that causes these disorders might be similar and could be targeted with specific treatment. Traditional categorical classification systems of psychiatric disorders do not reflect similarities in neurobiological dysfunction. The comorbidity and overlap between psychiatric disorders means that a dimensional classifications system based on underlying brain system dysfunction might be more appropriate. In this paper, the neural and neuromodulatory systems that contribute to goal-directed and habit systems are discussed. Account is taken of model-based and model-free computational learning mechanisms that are thought to give rise to goal-directed and habitual control respectively. Different psychiatric disorders that have a deficit in goal-directed behaviour or habit systems are then explored to see if there are similarities in the underlying neural systems despite differences in clinical presentation.
    [Show full text]